Cargando…
Influence of Antiplatelet and Anticoagulant Drug Use on Outcomes after Chronic Subdural Hematoma Drainage
We aim to describe the outcomes after chronic subdural hematoma drainage (CSDH) management in a large cohort of patients on antithrombotic drugs, either antiplatelets or anticoagulants, at presentation and to inform clinical decision making on the timing of surgery and recommencement of these drugs....
Autores principales: | Poon, Michael T.C., Rea, Catherine, Kolias, Angelos G., Brennan, Paul M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060161/ https://www.ncbi.nlm.nih.gov/pubmed/30526281 http://dx.doi.org/10.1089/neu.2018.6080 |
Ejemplares similares
-
Antiplatelet/Anticoagulant Agents and Chronic Subdural Hematoma in the Elderly
por: De Bonis, Pasquale, et al.
Publicado: (2013) -
Outcomes following surgery in subgroups of comatose and very elderly patients with chronic subdural hematoma
por: Christopher, Edward, et al.
Publicado: (2018) -
Predicting Chronic Subdural Hematoma Recurrence and Stroke Outcomes While Withholding Antiplatelet and Anticoagulant Agents
por: Zanaty, Mario, et al.
Publicado: (2020) -
Does Drain Position and Duration Influence Outcomes in Patients Undergoing Burr-Hole Evacuation of Chronic Subdural Hematoma? Lessons from a UK Multicenter Prospective Cohort Study
por: Glancz, Laurence Johann, et al.
Publicado: (2019) -
Subperiosteal/subgaleal drainage vs. subdural drainage for chronic subdural hematoma: A meta-analysis of postoperative outcomes
por: Chen, Chunhui, et al.
Publicado: (2023)